JSM 2015 Preliminary Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details
368 * ! Tue, 8/11/2015, 10:30 AM - 12:20 PM CC-616
Longitudinal Analysis — Contributed Papers
Biopharmaceutical Section , Biometrics Section
Chair(s): T. Ceesay, Merck
10:35 AM Making Better Dose Decisions — Zachary Skrivanek, Eli Lilly and Company
10:50 AM Two-Stage Approach to Evaluate Cardiovascular Risk of New Anti-Diabetic Therapies — Raymond Lam, Merck ; Shailaja Suryawanshi, Merck
11:05 AM A New Durability Analysis Method in Clinical Studies — John Xie, Johnson & Johnson ; Gordon Law, Johnson & Johnson ; Norm Bohidar, Johnson & Johnson ; Surya Mohanty, Johnson & Johnson ; Jiahui Li, Celgene Corporation
11:20 AM Joint Modeling of Longitudinal Responses and Survival Outcomes in Latent Class Framework — Yue Liu, Merck ; Lei Liu, Northwestern University ; Jianhui Zhou, University of Virginia
11:35 AM Assessing Association Between the Risk of Clinical Outcome Event and Patient's Disease Status That Vary by Time — Yiran Hu ; Bo Fu, AbbVie ; Yuanyuan Tang, AbbVie
11:50 AM On Two-Sample McNemar Test — Jim Xiang, Ortho McNeil Pharmaceutical
12:05 PM Methods of Assessing Treatment Failure or Response with Informative Censoring — Jun Zhao, AbbVie ; Qi Tang, AbbVie ; Bo Fu, AbbVie ; Claire L. Tsao, AbbVie




For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home